grant
Hemp-derived Cannabidiol for the treatment of cannabis use disorder in concentrate users: A double-blind placebo-controlled randomized trial
Organization UNIVERSITY OF COLORADOLocation Boulder, UNITED STATESPosted 15 Sept 2023Deadline 31 Jul 2028
NIHUS FederalResearch GrantFY202521+ years old9-ene-TetrahydrocannabinolAbstinenceAcuteAdultAdult HumanAffectiveAnxietyBloodBlood Reticuloendothelial SystemBlossomsCB1CB1 ReceptorCB1RCB2CB2 ReceptorCB2RCNR1 geneCNR2CNR2 geneCannabidiolCannabinoid Receptor CB1Cannabinoid Receptor CB2CannabinoidsCannabisCreatinineD9-tetrahydrocannabinolDSM-5DSM-VDSM5DataDelta-9-TetrahydrocannabinolDiagnostic and Statistical Manual of Mental Disorders, 5th editionDiagnostic and Statistical Manual of Mental Disorders-VDouble-Blind MethodDouble-Blind StudyDouble-BlindedDouble-Masked MethodDouble-Masked StudyDrugsFlowersGoalsHempInterventionIntoxicationLaboratoriesMarketingMeasuresMediatingMedicationMethodsMonitorParticipantPatient Self-ReportPharmaceutical PreparationsPhysiologicPhysiologicalPlacebo ControlPlacebosPlant BloomsPreparationProtocolProtocols documentationPublic HealthRandomizedRandomized, Controlled TrialsRecreationResearchSelf-ReportSham TreatmentStandardizationSymptomsTHC co-useTHC concentrationTHC exposureTHC useTestingTetrahydrocannabinolTetrahydrocannabinol co-useTetrahydrocannabinol useUnited StatesUrineWithdrawalWithdrawal Symptomadulthoodaffective disturbancecannabinoid receptor 1cannabinoid receptor 2cannabinoid receptor type 1cannabinoid receptor type 2cannabinoid type 1cannabis legalizationcannabis seekingcannabis usecannabis use disordercannabis userdelta(1)-THCdelta(1)-Tetrahydrocannabinoldelta(9)-THCdelta(9)-Tetrahydrocannabinoldisturbance in affectdrug adherencedrug compliancedrug rewarddrug/agenteffective therapyeffective treatmenthigh riskhigh risk grouphigh risk individualhigh risk peoplehigh risk populationlegal marijuanalegalized cannabislegalized marijuanamarijuana legalizationmarijuana usemarijuana use and disordermarijuana use disordermarijuana usermedication adherencemedication compliancemood alterationmood and affect disturbancemood disturbancemood dysfunctionnegative affectnegative affectivityphysical symptomplacebo control trialplacebo controlledplacebo controlled trialpreparationsprimary outcomepsychologicpsychologicalrandomisationrandomizationrandomized control trialrandomized placebo control trialrandomized placebo controlled trialrandomly assignedrecruitsham therapytelehealthtetrahydrocannabinol concentrationtetrahydrocannabinol exposuretrial comparingweek trialΔ(1)-THCΔ(1)-tetrahydrocannabinolΔ(9)-THCΔ(9)-tetrahydrocannabinolΔ-9-tetrahydrocannabinolΔ9-tetrahydrocannabinol
Description preview
Project Summary
As cannabis legalization continues to spread across the United States, average Δ9-tetrahydrocannabinol (THC)
concentrations in recreational products have significantly increased, with THC levels as high as 90-95%. Our
preliminary data suggest that concentrate use elicits blood THC levels more than twice as high as cannabis
flower…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click